Cargando…

Oral Bioavailability Comparison of Artemisinin, Deoxyartemisinin, and 10-Deoxoartemisinin Based on Computer Simulations and Pharmacokinetics in Rats

[Image: see text] Deoxyartemisinin, a compound separated from Artemisinin annua L., shows anti-inflammatory and antiulcer activities. 10-Deoxoartemisinin is a novel compound with a strong antimalarial effect derivatized from artemisinin. Compared to the famous antimalarial natural compound artemisin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Chunqing, Shi, Henan, Chen, Hong, Zhang, Keyu, Wang, Manyuan, Qiu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808142/
https://www.ncbi.nlm.nih.gov/pubmed/33458540
http://dx.doi.org/10.1021/acsomega.0c05465
_version_ 1783636851876167680
author Fu, Chunqing
Shi, Henan
Chen, Hong
Zhang, Keyu
Wang, Manyuan
Qiu, Feng
author_facet Fu, Chunqing
Shi, Henan
Chen, Hong
Zhang, Keyu
Wang, Manyuan
Qiu, Feng
author_sort Fu, Chunqing
collection PubMed
description [Image: see text] Deoxyartemisinin, a compound separated from Artemisinin annua L., shows anti-inflammatory and antiulcer activities. 10-Deoxoartemisinin is a novel compound with a strong antimalarial effect derivatized from artemisinin. Compared to the famous antimalarial natural compound artemisinin, deoxyartemisinin lacks the peroxide bridge structure, while 10-deoxoartemisinin remains this special peroxide bridge group but loses the 10-position keto group. To clarify their pharmacological differences, the absorption, distribution, metabolism, excretion (ADME) properties of artemisinin, deoxyartemisinin, and 10-deoxoartemisinin were first predicted using QikProp software. Also, their pharmacokinetic behaviors in rats were further evaluated by a rapid, sensitive, and specific liquid chromatography–tandem mass spectrometry (LC–MS/MS) method after oral and intravenous administration of each compound, in which deoxyartemisinin and 10-deoxoartemisinin were first evaluated for their pharmacokinetics. All parameters about ADME properties calculated by software met the criteria and the ADME performance order was 10-deoxoartemisinin > deoxyartemisinin > artemisinin. The oral bioavailability of artemisinin was calculated to be 12.2 ± 0.832%, which was about 7 times higher than that of deoxyartemisinin (1.60 ± 0.317%). For 10-deoxoartemisinin, its bioavailability (26.1 ± 7.04%) was superior to artemisinin at a degree of more than twice. Considering their chemical structures, losing the peroxide bridge might decrease the absorption rate of deoxyartemisinin in the gastrointestinal tract, while retaining the peroxide bridge but losing the 10-position ketone might improve the bioavailability of 10-deoxoartemisinin.
format Online
Article
Text
id pubmed-7808142
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-78081422021-01-15 Oral Bioavailability Comparison of Artemisinin, Deoxyartemisinin, and 10-Deoxoartemisinin Based on Computer Simulations and Pharmacokinetics in Rats Fu, Chunqing Shi, Henan Chen, Hong Zhang, Keyu Wang, Manyuan Qiu, Feng ACS Omega [Image: see text] Deoxyartemisinin, a compound separated from Artemisinin annua L., shows anti-inflammatory and antiulcer activities. 10-Deoxoartemisinin is a novel compound with a strong antimalarial effect derivatized from artemisinin. Compared to the famous antimalarial natural compound artemisinin, deoxyartemisinin lacks the peroxide bridge structure, while 10-deoxoartemisinin remains this special peroxide bridge group but loses the 10-position keto group. To clarify their pharmacological differences, the absorption, distribution, metabolism, excretion (ADME) properties of artemisinin, deoxyartemisinin, and 10-deoxoartemisinin were first predicted using QikProp software. Also, their pharmacokinetic behaviors in rats were further evaluated by a rapid, sensitive, and specific liquid chromatography–tandem mass spectrometry (LC–MS/MS) method after oral and intravenous administration of each compound, in which deoxyartemisinin and 10-deoxoartemisinin were first evaluated for their pharmacokinetics. All parameters about ADME properties calculated by software met the criteria and the ADME performance order was 10-deoxoartemisinin > deoxyartemisinin > artemisinin. The oral bioavailability of artemisinin was calculated to be 12.2 ± 0.832%, which was about 7 times higher than that of deoxyartemisinin (1.60 ± 0.317%). For 10-deoxoartemisinin, its bioavailability (26.1 ± 7.04%) was superior to artemisinin at a degree of more than twice. Considering their chemical structures, losing the peroxide bridge might decrease the absorption rate of deoxyartemisinin in the gastrointestinal tract, while retaining the peroxide bridge but losing the 10-position ketone might improve the bioavailability of 10-deoxoartemisinin. American Chemical Society 2020-12-28 /pmc/articles/PMC7808142/ /pubmed/33458540 http://dx.doi.org/10.1021/acsomega.0c05465 Text en © 2020 The Authors. Published by American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle Fu, Chunqing
Shi, Henan
Chen, Hong
Zhang, Keyu
Wang, Manyuan
Qiu, Feng
Oral Bioavailability Comparison of Artemisinin, Deoxyartemisinin, and 10-Deoxoartemisinin Based on Computer Simulations and Pharmacokinetics in Rats
title Oral Bioavailability Comparison of Artemisinin, Deoxyartemisinin, and 10-Deoxoartemisinin Based on Computer Simulations and Pharmacokinetics in Rats
title_full Oral Bioavailability Comparison of Artemisinin, Deoxyartemisinin, and 10-Deoxoartemisinin Based on Computer Simulations and Pharmacokinetics in Rats
title_fullStr Oral Bioavailability Comparison of Artemisinin, Deoxyartemisinin, and 10-Deoxoartemisinin Based on Computer Simulations and Pharmacokinetics in Rats
title_full_unstemmed Oral Bioavailability Comparison of Artemisinin, Deoxyartemisinin, and 10-Deoxoartemisinin Based on Computer Simulations and Pharmacokinetics in Rats
title_short Oral Bioavailability Comparison of Artemisinin, Deoxyartemisinin, and 10-Deoxoartemisinin Based on Computer Simulations and Pharmacokinetics in Rats
title_sort oral bioavailability comparison of artemisinin, deoxyartemisinin, and 10-deoxoartemisinin based on computer simulations and pharmacokinetics in rats
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808142/
https://www.ncbi.nlm.nih.gov/pubmed/33458540
http://dx.doi.org/10.1021/acsomega.0c05465
work_keys_str_mv AT fuchunqing oralbioavailabilitycomparisonofartemisinindeoxyartemisininand10deoxoartemisininbasedoncomputersimulationsandpharmacokineticsinrats
AT shihenan oralbioavailabilitycomparisonofartemisinindeoxyartemisininand10deoxoartemisininbasedoncomputersimulationsandpharmacokineticsinrats
AT chenhong oralbioavailabilitycomparisonofartemisinindeoxyartemisininand10deoxoartemisininbasedoncomputersimulationsandpharmacokineticsinrats
AT zhangkeyu oralbioavailabilitycomparisonofartemisinindeoxyartemisininand10deoxoartemisininbasedoncomputersimulationsandpharmacokineticsinrats
AT wangmanyuan oralbioavailabilitycomparisonofartemisinindeoxyartemisininand10deoxoartemisininbasedoncomputersimulationsandpharmacokineticsinrats
AT qiufeng oralbioavailabilitycomparisonofartemisinindeoxyartemisininand10deoxoartemisininbasedoncomputersimulationsandpharmacokineticsinrats